#europeancongressonobesity — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #europeancongressonobesity, aggregated by home.social.
-
https://www.europesays.com/dk/82808/ Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders #EliLilly #EuropeanCongressOnObesity #NovoNordisk #patients #WeightLoss
-
https://www.europesays.com/uk/958285/ Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders #EliLilly #EuropeanCongressOnObesity #Health #Medication #NovoNordisk #patients #UK #UnitedKingdom #WeightLoss
-
https://www.europesays.com/ie/483143/ Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders #Éire #EliLilly #EuropeanCongressOnObesity #Health #IE #Ireland #Medication #NovoNordisk #patients #WeightLoss
-
https://www.europesays.com/dk/71965/ Novo Nordisk to showcase Wegovy data at obesity meet #cagrisema #CardiovascularHealthRisks #EuropeanCongressOnObesity #EuropeanMedicinesAgency #istanbul #NovoNordisk #semaglutide #Type2Diabetes #Wegovy #WeightLossDrugs
-
https://www.europesays.com/dk/80449/ Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #BodyWeight #eco #EuropeanCongressOnObesity #JacobMartin #NovoNordisk #semaglutide #WeightLoss
-
https://www.europesays.com/dk/80332/ Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #BodyWeight #eco #EuropeanCongressOnObesity #JacobMartin #NovoNordisk #semaglutide #WeightLoss
-
https://www.europesays.com/dk/80320/ Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #BodyWeight #eco #EuropeanCongressOnObesity #JacobMartin #NovoNordisk #semaglutide #WeightLoss